Bill
Bill > HB1344
OK HB1344
OK HB1344Prescriptions for off-label medications; terms; moral, ethical, or religious exemptions; immunity from liability; good- faith effort; temporary privileges; at-home and outpatient dispensing; disciplinary action; exceptions; World Health Organization; effective date.
summary
Introduced
02/03/2025
02/03/2025
In Committee
02/04/2025
02/04/2025
Crossed Over
Passed
Dead
Introduced Session
2025 Regular Session
Bill Summary
An Act relating to prescriptions for off-label medications; defining terms; authorizing prescribing off-label prescriptions; allowing for moral, ethical, or religious exemptions; providing for immunity from liability; providing for good-faith effort; providing for temporary privileges; providing for at-home and outpatient dispensing; prohibiting disciplinary action; providing exceptions to disciplinary action; proscribing the World Health Organization jurisdiction in this state; providing for codification; and providing an effective date.
AI Summary
This bill introduces comprehensive provisions regarding off-label medication prescriptions in Oklahoma, establishing clear guidelines for healthcare professionals. The legislation defines key terms like "off-label drug" (a FDA-approved medication prescribed for a different medical purpose), and establishes that prescribers can issue prescriptions for off-label drugs after obtaining informed consent from patients, their parents/guardians, or healthcare power of attorney holders. The bill allows pharmacists and healthcare facilities to dispense off-label medications with certain protections, including moral, ethical, or religious exemptions and immunity from liability when dispensing drugs in good faith. Healthcare professionals are protected from disciplinary action for prescribing or dispensing off-label medications, except in cases of recklessness or gross negligence. The bill also explicitly prohibits the World Health Organization from having jurisdiction in Oklahoma and prevents state agencies from implementing WHO guidelines that would restrict off-label drug prescriptions. Notably, the bill does not require patients to have specific test results or prior exposure to a disease before receiving an off-label prescription, and it provides a mechanism for patients to access potentially life-saving treatments in challenging medical situations, such as allowing outside physicians to obtain temporary privileges in hospitals to prescribe off-label drugs. The legislation will become effective on November 1, 2025.
Sponsors (1)
Last Action
Second Reading referred to Rules (on 02/04/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://www.oklegislature.gov/BillInfo.aspx?Bill=hb1344&Session=2600 |
| State Bill Page | http://www.oklegislature.gov/BillInfo.aspx?Bill=hb1344&Session=2500 |
| BillText | https://www.oklegislature.gov/cf_pdf/2025-26%20INT/hB/HB1344%20INT.PDF |
| BillText | https://www3.oklegislature.gov/cf_pdf/2025-26%20INT/hB/HB1344%20INT.PDF |
| BillText | http://webserver1.lsb.state.ok.us/cf_pdf/2025-26%20INT/hB/HB1344%20INT.PDF |
Loading...